Research Studies
Cataract Studies:
► OMEROS302-ILR-004
A phase 3 randomized, double-masked, placebo-controlled study of pharmacokinetics of OMS302 and the effect of OMS302 on intraoperative pupil diameter and early postoperative pain in subjects undergoing intraocular lens replacement with phacoemulsification.
Participating Doctors: Steven Dunn, MD, W. Colby Stewart, MD, John Lim, MD, Fiaz Zaman, MD, Kevin Jong, MD, Richard Ou, MD
Coordinator: Santa Montelongo (832) 553-7133
Glaucoma Studies:
► Alcon Protocol C-11-034
Safety Extension of the efficacy and safety of a fixed combination of brinzolamide 1%/Brimonidine 0.2% compared to Brinzolomide 1%/ Brimonidine 0.2% all dosed three times daily in patients with open angle glaucoma and/or ocular hypertension
Coordinator: Gloria Orozco (832) 553-7142
► Alcon Protocol C-10-039
A Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost Ophthalmic Solution, 0.003% Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension
Coordinator: Yvette Degley (832) 553-7100
Uveitis Studies:
► Abbott Protocol M10-877
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Participating Doctor: Susan Wittenberg, MD
Coordinator: Yvette Degley (832) 553-7100
► Abbott Protocol M10-880
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Inactive Non-Infectious Intermediate-Posterior-, or Pan-uveitis
Participating Doctor: Susan Wittenberg, MD
Coordinator: Yvette Degley (832) 553-7100
► Abbott Protocol M11-327
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate-, Posterior-,or Pan-uveitis
Participating Doctor: Susan Wittenberg, MD
Coordinator: Yvette Degley (832) 553-7100
Bacterial Conjunctivitis Studies:
► Bausch & Lomb Protocol 646
A Randomized, Double-masked, Active-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Topical Besifloxacin Ophthalmic Suspension, 0.6% Compared with Gatifloxacin, 0.3% Ophthalmic Solution for the Treatment of Presumed Bacterial Conjunctivitis in Subjects from Birth to 31 Days of Age
Participating Doctor: Carlos Gonzales, MD, Kathryn Musgrove MD
Coordinator: Lydia Tapia (832) 553-7140
Amblyopia Studies:
► PEDIG ATS 15
Increasing Patching for Amblyopia
Participating Doctor: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
► PEDIG ATS 16
Augmenting Atropine Treatment for Amblyopia
Participating Doctor: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
► PEDIG ATS 17
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia
Participating Doctor: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
Strabismus Studies:
► PEDIG IXT 1
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia
Participating Doctor: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
► PEDIG IXT 2
A Randomized Clinical Trial of Observation versus Occlusion Therapy for Intermittent Exotropia
Participating Doctor: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
Upcoming Studies:
► Allergan Glaucoma Study on Bimatoprost/Timolol and formulation(s)